Related references
Note: Only part of the references are listed.NSAIDs Inhibit Tumorigenesis, but How?
Evrim Gurpinar et al.
CLINICAL CANCER RESEARCH (2014)
Time trends and outcome of gastrointestinal bleeding in the Veneto Region: A retrospective population based study from 2001 to 2010
Lucas G. Cavallaro et al.
DIGESTIVE AND LIVER DISEASE (2014)
GI-REASONS: A Novel 6-Month, Prospective, Randomized, Open-Label, Blinded Endpoint (PROBE) Trial
Byron Cryer et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Risk factors for severe nonsteroidal anti-inflammatory drug-induced small intestinal damage
Toshio Watanabe et al.
DIGESTIVE AND LIVER DISEASE (2013)
Low-dose aspirin in primary prevention: cardioprotection, chemoprevention, both, or neither?
Carlo Patrono
EUROPEAN HEART JOURNAL (2013)
Interference of NSAIDs with the thrombocyte inhibitory effect of aspirin: A placebo-controlled, ex vivo, serial placebo-controlled serial crossover study
I. L. Meek et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Comorbidities Affect Risk of Nonvariceal Upper Gastrointestinal Bleeding
Colin John Crooks et al.
GASTROENTEROLOGY (2013)
Comparison of gastrointestinal adverse effects between cyclooxygenase-2 inhibitors and non-selective, non-steroidal anti-inflammatory drugs plus proton pump inhibitors: a systematic review and meta-analysis
Saharat Jarupongprapa et al.
JOURNAL OF GASTROENTEROLOGY (2013)
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials
N. Bhala et al.
LANCET (2013)
Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!)
F. Berenbaum
OSTEOARTHRITIS AND CARTILAGE (2013)
Patient-level pooled analysis of adjudicated gastrointestinal outcomes in celecoxib clinical trials: meta-analysis of 51,000 patients enrolled in 52 randomized trials
Andrew Moore et al.
ARTHRITIS RESEARCH & THERAPY (2013)
Risk factors associated with a decrease ≥2 g/dL in haemoglobin and/or ≥10% haematocrit in osteoarthritis patients taking celecoxib or a nonselective NSAID plus a PPI in a large randomised controlled trial (CONDOR)
A. Lanas et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Prescription of and Adherence to Non-Steroidal Anti-Inflammatory Drugs and Gastroprotective Agents in At-Risk Gastrointestinal Patients
Angel Lanas et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Trends for Incidence of Hospitalization and Death Due to GI Complications in the United States From 2001 to 2009
Loren Laine et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Adherence to gastroprotection during cyclooxygenase 2 inhibitor treatment and the risk of upper gastrointestinal tract events: A population-based study
Vera E. Valkhoff et al.
ARTHRITIS AND RHEUMATISM (2012)
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Joep Perk et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2012)
Management of Helicobacter pylori infection-the Maastricht IV/ Florence Consensus Report
Peter Malfertheiner et al.
GUT (2012)
Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials
Annemijn M. Algra et al.
LANCET ONCOLOGY (2012)
Age As a Risk Factor
Ravi Dhingra et al.
MEDICAL CLINICS OF NORTH AMERICA (2012)
Concordance with Guideline Recommendations: previous and more recent Nonsteroidal anti-inflammatory Drug prescriptions in Quebec, Canada
Elham Rahme et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2012)
American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee
Marc C. Hochberg et al.
ARTHRITIS CARE & RESEARCH (2012)
The cost-effectiveness of celecoxib vs diclofenac in the treatment of osteoarthritis in the UK; an update to the NICE model using data from the CONDOR trial
N. Brereton et al.
JOURNAL OF MEDICAL ECONOMICS (2012)
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Joep Perk et al.
EUROPEAN HEART JOURNAL (2012)
The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel
Gerd Burmester et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Increased mortality in ankylosing spondylitis is related to disease activity
Gunnstein Bakland et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Low-Dose Naproxen Interferes With the Antiplatelet Effects of Aspirin in Healthy Subjects
Paola Anzellotti et al.
ARTHRITIS AND RHEUMATISM (2011)
Prescription patterns and appropriateness of NSAID therapy according to gastrointestinal risk and cardiovascular history in patients with diagnoses of osteoarthritis
Angel Lanas et al.
BMC MEDICINE (2011)
Clinical pharmacology of analgesic medicines in older people: impact of frailty and cognitive impairment
Andrew J. McLachlan et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
The Use of Antiplatelet Therapy in the Outpatient Setting: Canadian Cardiovascular Society Guidelines
Alan D. Bell et al.
CANADIAN JOURNAL OF CARDIOLOGY (2011)
Duration of Treatment With Nonsteroidal Anti-Inflammatory Drugs and Impact on Risk of Death and Recurrent Myocardial Infarction in Patients With Prior Myocardial Infarction A Nationwide Cohort Study
Anne-Marie Schjerning Olsen et al.
CIRCULATION (2011)
Risk of Upper Gastrointestinal Bleeding With Low-Dose Acetylsalicylic Acid Alone and in Combination With Clopidogrel and Other Medications
Luis A. Garcia Rodriguez et al.
CIRCULATION (2011)
Low Doses of Acetylsalicylic Acid Increase Risk of Gastrointestinal Bleeding in a Meta-Analysis
Angel Lanas et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Fixed-dose combination of enteric-coated naproxen and immediate-release esomeprazole has comparable efficacy to celecoxib for knee osteoarthritis: two randomized trials
Marc C. Hochberg et al.
CURRENT MEDICAL RESEARCH AND OPINION (2011)
Aging and osteoarthritis
Richard F. Loeser
CURRENT OPINION IN RHEUMATOLOGY (2011)
QUANTITATIVE ANALYSIS OF LOW-DOSE ASPIRIN-ASSOCIATED SMALL BOWEL INJURY USING A CAPSULE ENDOSCOPY SCORING INDEX
Hiroki Endo et al.
DIGESTIVE ENDOSCOPY (2011)
Effects of long-term PPI treatment on producing bowel symptoms and SIBO
Debora Compare et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2011)
Proton Pump Inhibitors Exacerbate NSAID-Induced Small Intestinal Injury by Inducing Dysbiosis
John L. Wallace et al.
GASTROENTEROLOGY (2011)
Non-steroidal anti-inflammatory drugs and risk of lower gastrointestinal adverse events: a nationwide study in Taiwan
Chia-Hsuin Chang et al.
GUT (2011)
Suboptimal gastroprotective coverage of NSAID use and the risk of upper gastrointestinal bleeding and ulcers: an observational study using three European databases
Eva M. van Soest et al.
GUT (2011)
Do musculoskeletal degenerative diseases affect mortality and cause of death after 10 years in Japan?
Masaki Tsuboi et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2011)
NSAIDs vs acetaminophen in knee and hip osteoarthritis: a systematic review regarding heterogeneity influencing the outcomes
S. P. J. Verkleij et al.
OSTEOARTHRITIS AND CARTILAGE (2011)
Incidence of gastrointestinal bleeding in patients with cardiovascular disease: buffered aspirin versus enteric-coated aspirin
Yoshikazu Hirata et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2011)
Cardiovascular Risk with Non-Steroidal Anti-Inflammatory Drugs: Systematic Review of Population-Based Controlled Observational Studies
Patricia McGettigan et al.
PLOS MEDICINE (2011)
All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study
Eveline Nueesch et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis
Sven Trelle et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Time-trends in gastroprotection with nonsteroidal anti-inflammatory drugs (NSAIDs)
V. E. Valkhoff et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Causes of Mortality in Patients With Peptic Ulcer Bleeding: A Prospective Cohort Study of 10,428 Cases
Joseph J. Y. Sung et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Assessment of gastrointestinal and cardiovascular risk in patients with osteoarthritis who require NSAIDs: the LOGICA study
Angel Lanas et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Acetaminophen Increases Blood Pressure in Patients With Coronary Artery Disease
Isabella Sudano et al.
CIRCULATION (2010)
Increased Incidence of Small Intestinal Bacterial Overgrowth During Proton Pump Inhibitor Therapy
Lucio Lombardo et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
Age-Related Changes in the Musculoskeletal System and the Development of Osteoarthritis
Richard F. Loeser
CLINICS IN GERIATRIC MEDICINE (2010)
Distribution of small intestinal mucosal injuries as a result of NSAID administration
Shunji Fujimori et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2010)
Severe chronic pain is associated with increased 10 year mortality. A cohort record linkage study
Nicola Torrance et al.
EUROPEAN JOURNAL OF PAIN (2010)
Nonsteroidal Antiinflammatory Drug-Related Injury to the Gastrointestinal Tract: Clinical Picture, Pathogenesis, and Prevention
Carmelo Scarpignato et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2010)
A Novel Composite Endpoint to Evaluate the Gastrointestinal (GI) Effects of Nonsteroidal Antiinflammatory Drugs Through the Entire GI Tract
Francis K. L. Chan et al.
JOURNAL OF RHEUMATOLOGY (2010)
Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial
Francis K. L. Chan et al.
LANCET (2010)
Correlation of pain relief with physical function in hand osteoarthritis: randomized controlled trial post hoc analysis
H. Richard Barthel et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Celecoxib Does Not Attenuate the Antiplatelet Effects of Aspirin and Clopidogrel in Healthy Volunteers
Wonjae Lee et al.
Korean Circulation Journal (2010)
FDA proposals to limit the hepatotoxicity of paracetamol (acetaminophen): are they reasonable?
Garry G. Graham et al.
INFLAMMOPHARMACOLOGY (2010)
Canadian consensus guidelines on long-term nonsteroidal anti-inflammatory drug therapy and the need for gastroprotection: benefits versus risks
A. Rostom et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis
Matthew C. Becker et al.
AMERICAN HEART JOURNAL (2009)
Time Trends and Impact of Upper and Lower Gastrointestinal Bleeding and Perforation in Clinical Practice
Angel Lanas et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Guidelines for Prevention of NSAID-Related Ulcer Complications
Frank L. Lanza et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Myths and facts in the use of anti-inflammatory drugs
Richard H. Hunt et al.
ANNALS OF MEDICINE (2009)
The interaction of ibuprofen and diclofenac with aspirin in healthy volunteers
M. P. Schuijt et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Low-Dose Aspirin Affects the Small Bowel Mucosa: Results of a Pilot Study With a Multidimensional Assessment
Edgardo Smecuol et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Gastroprotection among new chronic users of non-steroidal anti-inflammatory drugs: a study of utilization and adherence in the Netherlands
Michiel W. Van der Linden et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Nonsteroidal Anti-Inflammatory Drugs and Lower Gastrointestinal Complications
Angel Lanas et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2009)
Characteristics of small bowel injury in symptomatic chronic low-dose aspirin users: the experience of two medical centers in capsule endoscopy
Hiroki Endo et al.
JOURNAL OF GASTROENTEROLOGY (2009)
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
LANCET (2009)
Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement
Jack Cuzick et al.
LANCET ONCOLOGY (2009)
Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis
Nicholas Latimer et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
The antiplatelet effect of six non-steroidal anti-inflammatory drugs and their pharmacodynamic interaction with aspirin in healthy volunteers
Patrick A. Gladding et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use
Deepak L. Bhatt et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Management of Patients on Nonsteroidal Anti-inflammatory Drugs: A Clinical Practice Recommendation From the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Agents
Francis K. L. Chan et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Recommendations for use of selective and nonselective nonsteroidal antiinflammatory drugs: An American College of Rheumatology white paper
Sonali P. Desai et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials - The cross trial safety analysis
Scott D. Solomon et al.
CIRCULATION (2008)
Functionality and health-status benefits associated with reduction of osteoarthritis pain
Jeff R. Schein et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Assessment of the risk factors for colonic diverticular hemorrhage
Atsuo Yamada et al.
DISEASES OF THE COLON & RECTUM (2008)
Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man
Burkhard Hinz et al.
FASEB JOURNAL (2008)
Lower Gastrointestinal Events in a Double-Blind Trial of the Cyclo-Oxygenase-2 Selective Inhibitor Etoricoxib and the Traditional Nonsteroidal Anti-Inflammatory Drug Diclofenac
Loren Laine et al.
GASTROENTEROLOGY (2008)
NSAID-induced intestinal damage: are luminal bacteria the therapeutic target?
C. Scarpignato
GUT (2008)
Effects of ibuprofen on the magnitude and duration of aspirin's inhibition of platelet aggregation: Clinical consequences in stroke prophylaxis
Francis M. Gengo et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines
W. Zhang et al.
OSTEOARTHRITIS AND CARTILAGE (2008)
Use of NSAIDs and infection with Helicobacter pylori -: what does the rheumatologist need to know?
U. Kiltz et al.
RHEUMATOLOGY (2008)
Faecal blood loss with aspirin, nonsteroidal anti-inflammatory drugs and cyclo-oxygenase-2 selective inhibitors: systematic review of randomized trials using autologous chromium-labelled erythrocytes
R. Andrew Moore et al.
ARTHRITIS RESEARCH & THERAPY (2008)
Gastrointestinal tolerability of etoricoxib in rheumatoid arthritis patients: results of the etoricoxib vs diclofenac sodium gastrointestinal tolerability and effectiveness trial (EDGE-II)
K. Krueger et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Endoscopic ulcer rates in healthy subjects associated with use of aspirin (81 mg q.D.) alone or coadministered with celecoxib or naproxen: A randomized, 1-week trial
Jay L. Goldstein et al.
DIGESTIVE DISEASES AND SCIENCES (2008)
Decreasing incidence of symptomatic gastrointestinal ulcers and ulcer complications in patients with rheumatoid arthritis
K. S. S. Steen et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Are COX-2 inhibitors preferable to non-selective non-steroidal anti-inflammatory drugs in patients with risk of cardiovascular events taking low-dose aspirin?
Vibeke Strand
LANCET (2007)
Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment:: Double-blind, randomized, placebo-controlled trial
Helena T. J. I. de Leest et al.
HELICOBACTER (2007)
Cyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs: balancing gastrointestinal and cardiovascular risk
R. Andrew Moore et al.
BMC MUSCULOSKELETAL DISORDERS (2007)
Adherence to gastroprotection and the risk of NSAID-related upper gastrointestinal ulcers and haemorrhage
E. M. Van Soest et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Gastrointestinal safety of cyclooxygenase-2 inhibitors: A cochrane collaboration systematic review
Alaa Rostom et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Pain relief and pain-related sleep disturbance with extended-release tramadol in patients with osteoarthritis
Mark Kosinski et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
Clinical pharmacology in the geriatric patient
Sarah N. Hilmer et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2007)
Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy
J. L. Goldstein et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial
Francis Ka Leung Chan et al.
LANCET (2007)
Use of nonsteroidal Antiinflammatory drugs an update for clinicians - A scientific statement from the American Heart Association
Elliott M. Antman et al.
CIRCULATION (2007)
Frequency of analgesic use and risk of hypertension among men
John P. Forman et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison
Loren Laine et al.
LANCET (2007)
Hospitalization for gastrointestinal bleeding associated with non-steroidal anti-inflammatory drugs among elderly patients using low-dose aspirin: a retrospective cohort study
E. Rahme et al.
RHEUMATOLOGY (2007)
Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population
Luis A. Garcia Rodriguez et al.
GASTROENTEROLOGY (2007)
Risk of cardiovascular events in patients receiving celecoxib: A meta-analysis of randomized clinical trials
William B. White et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations
A. Lanas et al.
GUT (2006)
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison
Christopher P. Cannon et al.
LANCET (2006)
Cardiovascular and cerebrovascular events in the randomized, controlled Alzheimer's disease Anti-inflammatory Prevention Trial (ADAPT)
Barbara K. Martin et al.
PLOS CLINICAL TRIALS (2006)
A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50 279 patients at risk for coronary artery disease
Giuseppe G. L. Biondi-Zoccai et al.
EUROPEAN HEART JOURNAL (2006)
Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related gastroduodenal ulcer complications
Jay L. Goldstein et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Cardiovascular risk and inhibition of cyclooxygenase - A systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase
Patricia McGettigan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease
Giulia Renda et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials
Kenneth R. McQuaid et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials
Patricia M. Kearney et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Coxibs versus combination NSAID and PPI therapy for chronic pain: An exploration of the risks, benefits, and costs
Chin Hur et al.
ANNALS OF PHARMACOTHERAPY (2006)
Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events
AT Chan et al.
CIRCULATION (2006)
Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I study
G Singh et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Upper gastrointestinal complications among users of paracetamol
A González-Pérez et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2006)
Risk of cardiovascular events and celecoxib: a systematic review and meta-analysis
B Caldwell et al.
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE (2006)
Is non-steroidal anti-inflammaory drug (NSAID) enteropathy clinically more important than NSAID gastropathy?
D Adebayo et al.
POSTGRADUATE MEDICAL JOURNAL (2006)
Systematic review: the lower gastrointestinal adverse effects of non-steroidal anti-inflammatory drugs
L. Laine et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Prevention of anti-inflammatory drug-induced gastrointestinal damage: Benefits and risks of therapeutic strategies
Angel Lanas et al.
ANNALS OF MEDICINE (2006)
Consensus development conference on the use of nonsteroidal anti-inflammatory agents, including cyclooxygenase-2 enzyme inhibitors and aspirin
C. Mel Wilcox et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Time course and pattern of blood loss with ibuprofen treatment in healthy subjects
B Bowen et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2005)
National adherence to evidence-based guidelines for the prescription of nonsteroidal anti-inflammatory drugs
NS Abraham et al.
GASTROENTEROLOGY (2005)
Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke
AB Maulaz et al.
ARCHIVES OF NEUROLOGY (2005)
A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug use
A Lanas et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both
SD Solomon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Meta-analysis:: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users
M Vergara et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
W Zhang et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
A quantitative analysis of NSAID-Induced small bowel pathology by capsule enteroscopy
L Maiden et al.
GASTROENTEROLOGY (2005)
Current use of nonsteroidal antiinflammatory drugs and the risk of acute myocardial infarction
LM Fischer et al.
PHARMACOTHERAPY (2005)
Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial
RS Bresalier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention
SD Solomon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Effect of cardiovascular comorbidities and concomitant aspirin use on selection of cyclooxygenase inhibitor among rheumatologists
JD Greenberg et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2005)
Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo
JL Goldstein et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2005)
Visible small-intestinal mucosal injury in chronic NSAID users
DY Graham et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2005)
Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports
RA Moore et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Health-related quality of life in total hip and total knee arthroplasty - A qualitative and systematic review of the literature
O Ethgen et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2004)
The effects of nonselective non-aspirin non-steroidal anti-inflammatory medications on the risk of nonfatal myocardial infarction and their interaction with aspirin
SE Kimmel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Review article:: should NSAID/low-dose aspirin takers be tested routinely for H-pylori infection and treated if positive?: Implications for primary risk of ulcer and ulcer relapse after initial healing
RH Hunt et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Guidelines for the appropriate use of non-steroidal anti-inflammatory drugs, cyclo-oxygenase-2-specific inhibitors and proton pump inhibitors in patients requiring chronic anti-inflammatory therapy
RW Dubois et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial
ME Farkouh et al.
LANCET (2004)
Efficacy and safety of four doses of lumiracoxib versus diclofenac in patients with knee or hip primary osteoarthritis:: A phase II, four-week, multicenter, randomized, double-blind, placebo-controlled trial
TJ Schnitzer et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2004)
Does paracetamol (acetaminophen) reduce the pain of osteoarthritis?: a meta-analysis of randomised controlled trials
W Zhang et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Treatment costs to prevent or treat upper gastrointestinal adverse events associated with NSAIDs - A review
E Rahme et al.
DRUG SAFETY (2004)
Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population
LAG Rodríguez et al.
CIRCULATION (2004)
A comparison of the efficacy and safety nonsteroidal antiinflammatory agents acetaminophen in the treatment of osteoarthritis: A meta-analysis
C Lee et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2004)
Aspirin, ibuprofen, and mortality after myocardial infarction: retrospective cohort study
JP Curtis et al.
BRITISH MEDICAL JOURNAL (2003)
EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)
KM Jordan et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs
T Kurth et al.
CIRCULATION (2003)
Characterization of etoricoxib, a novel, selective COX-2 inhibitor
A Dallob et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Effect of ibuprofen on cardioprotective effect of aspirin
TM MacDonald et al.
LANCET (2003)
Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use
L Laine et al.
GASTROENTEROLOGY (2003)
Complementary studies of the gastrointestinal safety of the cyclo-oxygenase-2-selective inhibitor etoricoxib
RH Hunt et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Adherence to proton pump inhibitors or H-2-receptor antagonists during the use of non-steroidal anti-inflammatory drugs
MCJM Sturkenboom et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Underutilization of preventive strategies in patients receiving NSAIDs
MCJM Sturkenboom et al.
RHEUMATOLOGY (2003)
Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis
FKL Chan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Frequency of analgesic use and risk of hypertension in younger women
GC Curhan et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials
JJ Deeks et al.
BRITISH MEDICAL JOURNAL (2002)
The hidden costs of arthritis treatment and the cost of new therapy - the burden of non-steroidal anti-inflammatory drug gastropathy
RA Moore
RHEUMATOLOGY (2002)
Comparison of thromboembolic events in patients treated with Celecoxib, a cyclooxygenase-1 specific inhibitor, versus Ibuprofen or Diclofenac
WB White et al.
AMERICAN JOURNAL OF CARDIOLOGY (2002)
GP and patient perspectives on treatment with non-steroidal anti-inflammatory drugs for the treatment of pain in osteoarthritis
B Crichton et al.
CURRENT MEDICAL RESEARCH AND OPINION (2002)
Cyclooxygenase inhibitors and the antiplatelet effects of aspirin.
F Catella-Lawson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
A high level of cyclooxygenase-2 inhibitor selectivity is associated with a reduced interference of platelet cyclooxygenase-1 inactivation by aspirin
M Ouellet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The impact of chronic pain in the community
BH Smith et al.
FAMILY PRACTICE (2001)
A comparison of outcomes in osteoarthritis patients undergoing total hip and knee replacement surgery
CJM Bachmeier et al.
OSTEOARTHRITIS AND CARTILAGE (2001)
Pain as a reason to visit the doctor: a study in Finnish primary health care
P Mantyselka et al.
PAIN (2001)
EULAR recommendations for the management of knee osteoarthritis:: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)
A Pendleton et al.
ANNALS OF THE RHEUMATIC DISEASES (2000)
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis.
C Bombardier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis - The CLASS study: A randomized controlled trial
FE Silverstein et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Using practice guidelines to allocate medical technologies - An ethics framework
MK Giacomini et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2000)
Antiplatelet effects of MK-852, a platelet fibrinogen receptor antagonist, in healthy volunteers
HE Greenberg et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2000)
Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: A randomized, controlled trial
PT Leese et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2000)
Which chronic conditions are associated with better or poorer quality of life?
MAG Sprangers et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2000)
Share Paper
